Optimal investment in HIV prevention programs: more is not always better
- 136 Downloads
This paper develops a mathematical/economic framework to address the following question: Given a particular population, a specific HIV prevention program, and a fixed amount of funds that could be invested in the program, how much money should be invested? We consider the impact of investment in a prevention program on the HIV sufficient contact rate (defined via production functions that describe the change in the sufficient contact rate as a function of expenditure on a prevention program), and the impact of changes in the sufficient contact rate on the spread of HIV (via an epidemic model). In general, the cost per HIV infection averted is not constant as the level of investment changes, so the fact that some investment in a program is cost effective does not mean that more investment in the program is cost effective. Our framework provides a formal means for determining how the cost per infection averted changes with the level of expenditure. We can use this information as follows: When the program has decreasing marginal cost per infection averted (which occurs, for example, with a growing epidemic and a prevention program with increasing returns to scale), it is optimal either to spend nothing on the program or to spend the entire budget. When the program has increasing marginal cost per infection averted (which occurs, for example, with a shrinking epidemic and a prevention program with decreasing returns to scale), it may be optimal to spend some but not all of the budget. The amount that should be spent depends on both the rate of disease spread and the production function for the prevention program. We illustrate our ideas with two examples: that of a needle exchange program, and that of a methadone maintenance program.
KeywordsHIV/AIDS Resource allocation HIV prevention Cost–effectiveness analysis
This work was supported by a grant from the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH; grant DA-R01-15612).
- 1.World Health Organization (2007) Global HIV prevalence has levelled off. http://www.who.int/mediacentre/news/releases/2007/pr61/en/index.html. Accessed March 7, 2008
- 2.Joint United Nations Programme on HIV/AIDS (UNAIDS) (2005) Resource needs for an expanded response to AIDS in low- and middle-income countries. http://www.unaids.org/html/pub/publications/irc-pub06/resourceneedsreport_24jun05_en_pdf.pdf. Accessed March 7, 2008
- 4.Ruiz M, Gable A, Kaplan EH et al. (eds) (2001) No time to lose: getting more from HIV prevention. National Academy Press, Washington, DCGoogle Scholar
- 7.Kahn JG, Kegeles SM, Hays R et al (2001) The cost–effectiveness of the Mpowerment Project, a community-level intervention for young gay men. J Acquir Immune Defic Syndr 27(5):482–491Google Scholar
- 21.Kaplan EH (1998) Economic evaluation and HIV prevention community planning. A policy analyst’s perspective. In: Holtgrave DR (ed) Handbook of HIV prevention policy analysis. Plenum, New York, pp 177–193Google Scholar
- 22.Friedrich CM, Brandeau ML (1998) Using simulation to find optimal funding levels for HIV prevention programs with different costs and effectiveness. In: Katzper M, Anderson JG (eds) Proceedings of the 1998 Medical Sciences Simulation Conference. The Society for Computer Simulation International, San Diego, pp 58–64Google Scholar
- 31.World Health Organization (2002) The world health report 2002 - reducing risks, promoting healthy life. World Health Organization, Geneva, SwitzerlandGoogle Scholar
- 32.Herbst JH, Sherba RT, Crepaz N et al (2005) A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr 39(2):228–241Google Scholar
- 33.Kaplan EH (1989) Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis 11(2):289–298 Published erratum appears in Rev Infect Dis 11(4):672, 1989Google Scholar
- 37.Bailey NTJ (1975) The mathematical theory of infectious diseases and its applications. Hafner, New YorkGoogle Scholar
- 45.National Aeronautics and Space Administration (2007) GDP inflation calculator. http://cost.jsc.nasa.gov/inflateGDP.html. Accessed March 7, 2008